References
- Khudhair AA, Salih AA, Kadhum AJ. Congenital factor VII deficiency in iraqi children (single Centre experience). Pak J Med Sci. 2020;36(2):177–181.
- Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015;125(13):2052–2061.
- Hoffman M, Colina CM, McDonald AG, et al. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost. 2007;5(7):1403–1408.
- Siboni SM, Biguzzi E, Mistretta C, et al. Long-term prophylaxis in severe factor VII deficiency. Haemophilia. 2015;21(6):812–819.
- Mumford AD, Ackroyd S, Alikhan R, et al. BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom haemophilia Centre doctors' organization guideline on behalf of the british committee for standards in haematology. Br J Haematol. 2014;167(3):304–326.
- Sevenet P-O, Kaczor DA, Depasse F. Factor VII deficiency: from basics to clinical laboratory diagnosis and patient management. Clin Appl Thromb Hemost. 2017;23(7):703–710.
- Mariani G, Bernardi F. Factor VII deficiency. Semin Thromb Hemost. 2009;35(4):400–406.
- Lapecorella M, Mariani G, International Registry on Congenital Factor VII Deficiency. Factor VII deficiency: defining the clinical picture and optimizing therapeutic options. Haemophilia. 2008;14(6):1170–1175.
- Bernardi F, Dolce A, Pinotti M, et al. International Factor VII Deficiency Study Group. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B. J Thromb Haemost. 2009;7(5):774–779.
- Peyvandi F, Palla R, Menegatti M, et al. ON BEHALF OF THE EUROPEAN NETWORK OF RARE BLEEDING DISORDERS (EN-RBD) GROUP. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the european network of rare bleeding disorders. J Thromb Haemost. 2012;10(4):615–621.
- de Moerloose P, Schved JF, Nugent D. Rare coagulation disorders: fibrinogen, factor VII and factor XIII. Haemophilia. 2016;22:61–65.
- Jain S, Donkin J, Frey MJ, et al. Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic. JBM. 2018;Volume 9:211–218.
- Napolitano M, Giansily-Blaizot M, Dolce A, et al. Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the seven treatment evaluation registry (STER). Haematologica. 2013;98(4):538–544.
- Di Minno MND, Napolitano M, Dolce A, et al. the STER Study Group. Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry. Br J Haematol. 2018;180(4):563–570.
- Salcioglu Z, Akcay A, Sen HS, et al. Factor VII deficiency: a single-center experience. Clin Appl Thromb Hemost. 2012;18(6):588–593.
- Mariani G, Herrmann FH, Dolce A, et al. International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. J. Thromb Haemost. 2005;93(3):481–487.
- Herrmann FH, Wulff K, Auerswald G, et al. Greifswald Factor FVII Deficiency Study Group. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and latin america with mutations in the factor 7 gene. Haemophilia. 2009;15(1):267–280.
- Millar DS, Kemball-Cook G, McVey JH, et al. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet. 2000;107(4):327–342.
- Richards EJ. Inherited epigenetic variation-revisiting soft inheritance. Nat Rev Genet. 2006;7(5):395–401.
- Oymak Y, Yıldırım AT, Yaman Y, et al. Faktör VII eksikliği olan hastalarda kanama semptomlarının ve faktör VII aktivitesi ile ilişkisinin değerlendirilmesi [evaluation of bleeding symptoms of the patients with factor VII deficiency and its association with factor VII activity]. buchd. 2013;2(2):102–106.
- Koç BK, Zülfikar B. Kalıtsal faktör VII eksikliği olanların klinik sorunları ve uygulanan cerrahi girişimler [clinical problems and surgical interventions in inherited factor VII deficiency]. Türk Pediatri Ars. 2020;55(2):184–190.
- 1. Bernardi F, Mariani G. Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis. Haematologica. 2021;106(2):351–362.
- Di Minno MN, Dolce A, Mariani G, the STER Study GroupBleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thromb Haemost. 2013;109(06):1051–1059.
- Napolitano M, Di Minno MN, Batorova A, et al. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies. Haemophilia. 2016;22(5):752–759.
- Bilici M, Karaman S. Nadir faktör eksikliklerinde ayırıcı tanı [differential diagnosis in rare coagulation disorders]. Sağlık Bilimlerinde İleri Araşt. Derg. 2019;2(3):126–129.
- Giansily-Blaizot M, Verdier R, Biron-Adréani C, et al. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk? Haematologica. 2004;89(6):704–709.
- Owaidah T, Saleh M, Alzahrani H, et al. Prevalence of bleeding symptoms among adolescents and young adults in the Capital city of Saudi Arabia. Adv Hematol. 2018;2018 (:1858241–1858248.
- Baumann Kreuziger LM, Morton CT, Reding MT. Is prophylaxis required for delivery in women with factor VII deficiency? Haemophilia. 2013;19(6):827–832.
- Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood. 2019;133(5):415–424.
- Berrettini M, Mariani G, Schiavoni M, et al. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency. Haematologica. 2001;86(6):640–645.